Trial Profile
Effectiveness of Ezetimibe in NAFLD patients with hyperlipidemia
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 08 Jul 2014
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Hyperlipidaemia; Non-alcoholic fatty liver disease
- Focus Therapeutic Use
- 08 Jul 2014 New trial record